Relaxo Footwears Ltd Valuation Shifts Signal Heightened Price Premium

Valuation Metrics Reflect Elevated Price Levels

Relaxo Footwears currently trades at a P/E ratio of 50.20, a significant premium relative to its historical averages and many peers in the footwear sector. This elevated P/E places the company firmly in the "very expensive" category, a shift from its previous "expensive" rating. The price-to-book value stands at 4.08, further underscoring the premium investors are willing to pay for the stock relative to its net asset base.

Enterprise value to EBITDA (EV/EBITDA) is another critical metric where Relaxo registers 24.12, indicating a stretched valuation compared to more moderate levels seen in some competitors. For context, Metro Brands, another footwear player rated as very expensive, trades at a higher P/E of 67.82 and EV/EBITDA of 33.15, while Bata India, rated attractive, has a P/E of 52.69 but a notably lower EV/EBITDA of 13.58. This comparison highlights that while Relaxo is expensive, it is not the most overvalued in its peer group.

Price Momentum and Market Performance

Relaxo’s share price has demonstrated strong momentum recently, with a day change of 4.38% and a one-month return of 26.66%, significantly outperforming the Sensex’s 2.55% over the same period. The stock’s current price stands at ₹365.55, up from the previous close of ₹350.20, though it remains well below its 52-week high of ₹531.45. Despite this recent rally, the year-to-date return remains negative at -9.56%, closely mirroring the Sensex’s -9.46%, indicating broader market headwinds have weighed on the stock over the longer term.

Longer-term returns paint a more challenging picture, with Relaxo underperforming the Sensex substantially over three and five years, delivering -60.36% and -66.77% respectively, compared to Sensex gains of 21.73% and 47.46%. However, over a 10-year horizon, Relaxo has managed a 48.00% return, though still trailing the Sensex’s robust 189.78% growth.

Comparative Valuation and Peer Analysis

When benchmarked against peers, Relaxo’s valuation remains on the higher side but is not an outlier. Metro Brands, also classified as very expensive, trades at a P/E of 67.82 and EV/EBITDA of 33.15, indicating even greater premium pricing. Conversely, companies like Bata India and Sheela Foam are rated attractive or very attractive, with Bata’s P/E at 52.69 and Sheela Foam’s at 51.14 but with significantly lower PEG ratios of 0.00 and 0.43 respectively, suggesting better growth-adjusted valuations.

Relaxo’s PEG ratio of 9.56 is notably high, signalling that the stock’s price growth has outpaced earnings growth substantially. This contrasts with peers such as Sheela Foam and Redtape, which have PEG ratios below 1.0, indicating more reasonable valuations relative to expected earnings growth. The company’s return on capital employed (ROCE) and return on equity (ROE) stand at 9.74% and 8.13% respectively, reflecting moderate profitability but not sufficiently strong to justify the elevated multiples.

Market Capitalisation and Analyst Sentiment

Relaxo Footwears is classified as a small-cap stock, which often entails higher volatility and sensitivity to market sentiment. The company’s Mojo Score has improved to 52.0 with a Mojo Grade upgrade from Sell to Hold as of 16 June 2026, signalling a cautious but more favourable outlook from analysts. This upgrade reflects recognition of the company’s recent price momentum but also acknowledges valuation concerns that temper enthusiasm.

Dividend yield remains modest at 0.83%, which may limit appeal for income-focused investors. The elevated valuation metrics suggest that investors are pricing in significant growth expectations, which will require consistent operational performance and margin expansion to be realised.

Investment Implications and Outlook

Investors considering Relaxo Footwears should weigh the company’s recent price appreciation against its stretched valuation metrics. The very expensive P/E and high PEG ratio suggest that the market is pricing in robust future earnings growth, which may be challenging to sustain given the company’s moderate ROCE and ROE figures. Additionally, the stock’s underperformance relative to the Sensex over medium and long-term periods raises questions about its ability to deliver consistent shareholder returns.

While the recent upgrade to a Hold rating indicates some improvement in sentiment, the valuation premium warrants caution. Investors may prefer to monitor quarterly earnings and margin trends closely to assess whether Relaxo can justify its lofty multiples through operational improvements or market share gains.

Comparative analysis with peers reveals that more attractively valued footwear companies exist, some with better growth-adjusted valuations and profitability metrics. This suggests that selective stock picking within the sector could yield superior risk-adjusted returns.

In summary, Relaxo Footwears Ltd’s valuation shift to very expensive reflects heightened investor optimism but also elevates risk. A balanced approach, considering both the company’s momentum and valuation stretch, is advisable for investors navigating the current market environment.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today